What is Biosensing Instrument?
Biosensing Instrument specializes in the design of award-winning label-free molecular interaction instruments leveraging Surface Plasmon Resonance (SPR) technology. Their product portfolio includes the SPRm 200 system, which combines optical microscopy with SPR for real-time measurement of binding reactions at cellular membranes, alongside a series of high-performance benchtop SPR instruments. The company serves the pharmaceutical industry and academic research sectors, providing bioanalytical tools and measurement services to accelerate drug discovery. Their versatile applications extend to life science research, electrochemical measurements, and chemical vapor sensing, positioning them as a key player in advanced bioanalytical instrumentation.
How much funding has Biosensing Instrument raised?
Biosensing Instrument has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Biosensing Instrument?
With substantial late-stage funding, Biosensing Instrument is poised for accelerated growth and market expansion. The recent strategic investment will likely fuel further research and development into novel SPR applications, enhance manufacturing capabilities, and broaden their global sales and support network. This capital infusion is expected to solidify their position in the competitive life sciences instrumentation market, enabling them to address the increasing demand for precise and efficient molecular interaction analysis in drug discovery and diagnostics.
See full Biosensing Instrument company page
